A 64-year-old man presented in April 2020 to the emergency department (ED) with severe
and worsening odynophagia of 7-weeks’ duration, associated with a week of hemoptysis
with 2 to 3 episodes a day of bright red sputum and intermittent night sweats.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Chao NJ. Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease. Section Editor: Negrin RS; Deputy Editor: Rosmarin AG. UpToDate, Waltham, MA. Available at: https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-grading-of-acute-graft-versus-host-disease. Accessed June 14, 2021.
- Nikolsky's sign on the gingival mucosa: a clinical tool for oral health practitioners.J Periodontol. 2008; 79: 2241-2246
- Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: a retrospective cohort study.J Am Acad Dermatol. 2020; 83: 1654-1658
- Videofluoroscopy of the pharynx and esophagus in chronic graft-versus-host disease.Abdom Imaging. 1994; 19: 191-194
Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(suppl S25):e1-e12.
- Oral complications of chronic graft-Versus-host disease.J Natl Cancer Inst Monogr. 2019; : lgz007
- Adv Exp Med Biol. 2003; 528 (Complex aphthosis.): 311-316
- A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects.J Clin Exp Hematop. 2019; 59: 64-71
- A rare case of cytomegalovirus induced oral ulcer in an immunocompromised patient.J Oral Med Oral Surg. 2019; 25: 22
- How we treat oral chronic graft-versus-host disease.Blood. 2012; 120: 3407-3418
- Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease.Biol Blood Marrow Transplant. 2015; 21: 503-508
- Paraneoplastic pemphigus: two cases of intra-abdominal malignancy presenting solely as treatment refractory oral ulceration.J Dermatol. 2015; 42: 300-304
- Mucous membrane pemphigoid and oral blistering diseases.Clin Exp Dermatol. 2019; 44: 732-739
- Pemphigoid diseases.Lancet. 2013; 381: 320-332
- Safety and efficacy of rituximab-based first line treatment of chronic GVHD.Bone Marrow Transplant. 2019; 54: 1218-1226
- Image gallery: juvenile cutaneous chronic graft-versus-host disease presenting as bullous pemphigoid.Br J Dermatol. 2017; 177: e69
- Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab.Int J Dermatol. 2019; 58: 240-241
- Development of mucous membrane pemphigoid with antibodies to the β3 subunit of laminin 332 and bronchiolitis obliterans in a patient with chronic graft-versus-host disease.Eur J Dermatol. 2015; 25: 505-506
- Bullous pemphigoid after allogeneic hematopoietic stem cell transplantation.Pediatr Int. 2015; 57: 480-483
- Detection of apoptotic keratinocytes in a case of bullous pemphigoid developed after graft-versus-host disease.Acta Derm Venereol. 2014; 94: 231-232
- Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.Eur J Dermatol. 2013; 23: 562-564
- Mucous membrane pemphigoid with antibodies to the β3 subunit of laminin 332.J Dermatol. 2011; 38: 1082-1084
- Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia.Bone Marrow Transplant. 2010; 45: 195-196
- Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.J Am Acad Dermatol. 2007; 56: S94-S97
- A case of bullous pemphigoid associated with graft versus host disease.Nishi Nihon Hifuka. 2004; 66: 269-273
- Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease.Bone Marrow Transplant. 2002; 30: 327-329
- Tense blisters after bone marrow transplantation.Arch Dermatol. 1999; 135: 81-86
- Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.Bone Marrow Transplant. 1992; 10: 377-379
- Pemphigoîde bulleuse succédant à une réaction du greffon contre l'hôte après allogreffe de moelle osseuse. Bullous pemphigoid following graft-versus-host reaction after bone marrow allograft.Presse Med. 1988; 17: 1367-1368
- Development of bullous pemphigoid after allogeneic bone marrow transplantation: report of a case.Transplantation. 1986; 42: 320-322
Article info
Publication history
Published online: August 15, 2021
Accepted:
August 9,
2021
Received in revised form:
July 31,
2021
Received:
July 10,
2021
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
